| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4861303
Max Phase: Preclinical
Molecular Formula: C20H23N7O3
Molecular Weight: 409.45
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(NC1CCN(c2ncnc3[nH]ccc23)CC1)N[C@@H](C(=O)NO)c1ccccc1
Standard InChI: InChI=1S/C20H23N7O3/c28-19(26-30)16(13-4-2-1-3-5-13)25-20(29)24-14-7-10-27(11-8-14)18-15-6-9-21-17(15)22-12-23-18/h1-6,9,12,14,16,30H,7-8,10-11H2,(H,26,28)(H,21,22,23)(H2,24,25,29)/t16-/m1/s1
Standard InChI Key: PVGIKFLEJLNHQK-MRXNPFEDSA-N
Associated Targets(non-human)
Aminopeptidase N 1645 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 409.45 | Molecular Weight (Monoisotopic): 409.1862 | AlogP: 1.47 | #Rotatable Bonds: 5 |
| Polar Surface Area: 135.27 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.68 | CX Basic pKa: 7.43 | CX LogP: 0.74 | CX LogD: 0.67 |
| Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.32 | Np Likeness Score: -1.22 |
References
| 1. Liu Q, Dong H, Zhao W, Zhang G, Li S, Xu Q, Zhang Y.. (2021) Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors., 12 (12.0): [PMID:34917257] [10.1021/acsmedchemlett.1c00504] |
Source
Source(1):